SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

1 Apr 2022 07:00

RNS Number : 8664G
Numis Corporation PLC
01 April 2022
 

1 April 2022

 

Numis Corporation Plc

Trading Update

 

Numis Corporation Plc ("Numis"), a leading independent investment banking group, today issues a trading update in respect of the six month period ended 31 March 2022

 

Key Highlights

 

· Overall, revenue for first half is expected to be in the region of £74m, approximately 36% below the record six month performance achieved in the comparative period.

· M&A and Growth Capital Solutions delivered strong revenues in line with H121 performance, but this was offset by a decline in equity capital markets activity across the industry which impacted our Investment Banking performance.

· Within our Equities division, Institutional income delivered a robust performance in line with the second half of FY21, whilst the challenging market conditions in recent weeks adversely impacted the profitability of our trading book. In aggregate, Equities revenues for the first half are expected be around 20% below the record H121 performance.

· Outlook:

o M&A continues to be positive with a large number of announced but ongoing transactions, and a strong pipeline of future business

o The outlook for capital markets is less certain, however, markets have regained some stability and activity is expected to recover to some extent during the second half.

 

Summary review

 

Investment Banking

 

Our strategic focus on diversifying the Investment Banking business in recent years has mitigated the impact of the difficult market backdrop. M&A advisory revenues in the first half are in line with the record performance achieved in the prior year and Growth Capital Solutions, our private markets business, has delivered an equally resilient performance in line with the prior year. 

 

More broadly however, Investment Banking revenues for the half have been impacted by a deterioration in market conditions for equity issuance and in particular, over the last three months concerns related to the acceleration and persistence of inflation. This has been overlayed with the recent geo-political, economic and capital markets impacts of the war in Ukraine and together have suppressed UK equity capital markets in our second quarter to activity levels approaching a 10 year low.

 

Equities

 

Whilst Institutional income, and Research payments in particular, delivered a robust performance, our trading profit has been negatively impacted by the extreme market volatility of the last eight weeks of the period. We have seen high levels of interactions with our institutional clients during the last few weeks, which demonstrates that investors turn to Numis for advice and guidance when there are periods of heightened uncertainty.

 

 

Outlook

 

Notwithstanding market volatility, the outlook for M&A in the second half continues to be positive. We have good visibility of upcoming advisory fees from transactions already announced and our overall M&A pipeline for the second half is strong. The outlook for capital markets is less certain, however, markets have mostly recovered to levels apparent before the war in Ukraine, which gives us some confidence that market activity will recover to some extent during the second half. Whilst we do not anticipate IPOs to feature prominently in the near term, the current pipeline reflects the ambition of our broad corporate client base to finance their inorganic growth strategies.

 

We have a strong balance sheet and a long track record of delivering growth and consistent returns across market cycles. Challenging market conditions typically present opportunities for market share gains across our core products, where we believe our integrated model offers clients access to high quality, experienced and insightful advice. Similarly, we will continue to diversify the business through selective investment in our strategic growth products. This includes the development of our European capability from our Dublin office which we anticipate will commence trading during the second half.

 

Numis will announce half year results for the six month period ended 31 March 2022 on 6 May 2022. 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018

 

Contacts:

 

Numis Corporation:

Noreen Biddle Shah, Head of Corporate Communications 020 7260 1441

 

FTI Consulting LLP:

Edward Bridges 07768 216607

Daisy Hall 07807 298568

 

Grant Thornton UK LLP (Nominated Adviser):

Philip Secrett 020 7728 2578

Harrison Clarke 020 7184 4384

 

Notes for Editors

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors. Numis is listed on AIM, and has offices in London and New York.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUARARUVUOOUR
Date   Source Headline
20th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Mar 201811:06 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20183:00 pmRNSDirectors' Dealing
9th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20184:00 pmRNSDirector's Dealing
23rd Feb 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20182:13 pmRNSHolding(s) in Company
15th Feb 201812:45 pmRNSHolding(s) in Company
13th Feb 20181:41 pmRNSHolding(s) in Company
13th Feb 201811:28 amRNSHolding(s) in Company
6th Feb 20181:17 pmRNSResult of AGM
6th Feb 20187:00 amRNSTrading update
5th Feb 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jan 201812:00 pmRNSDirectors' Dealing
16th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jan 20187:00 amRNSBoard Change
5th Jan 20189:14 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20187:00 amRNSAnnual Report and Annual General Meeting Notice
13th Dec 20173:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
6th Dec 20177:00 amRNSPreliminary Results for the year ended 30 Sep 2017
29th Nov 20174:28 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 201711:32 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20177:32 amRNSTrading Update
29th Sep 20177:00 amRNSPurchase of Shares in Close Period
21st Sep 20177:00 amRNSCancellation of Share Premium Account
20th Sep 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20173:00 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSDirector's Dealing
12th Sep 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20174:32 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20174:34 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 201711:09 amRNSHolding(s) in Company
1st Sep 20172:24 pmRNSHolding(s) in Company
1st Sep 20172:23 pmRNSDirector's Dealing
1st Sep 201712:26 pmRNSTransaction in Own Shares and Total Voting Rights
30th Aug 201711:00 amRNSResult of General Meeting
11th Aug 20171:00 pmRNSNotice of Meeting and Proposed Capital Reduction
9th Aug 20173:34 pmRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jul 20177:01 amRNSBoard Changes
28th Jul 20177:00 amRNSTrading Update
13th Jul 201711:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.